A clinical trial to find out the optimal oral iron dosing schedule for the prevention of anaemia in pregnant women (PANDA-Dose study)
Not Applicable
Completed
- Conditions
- Iron supplementation in pregnant womenPregnancy and Childbirth
- Registration Number
- ISRCTN12911644
- Lead Sponsor
- HS Blood and Transplant
- Brief Summary
2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39208353/ (added 02/09/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 300
Inclusion Criteria
1. Healthy non-anaemic pregnant women of all parities (haemoglobin concentration (Hb) > = 110 g/l) at booking or screening.
2. 13 weeks + 6 days gestation or less
3. Age 18 and above
4. Able to give informed consent and willing to fulfil trial requirements
Exclusion Criteria
Women with the following conditions will be excluded:
1. Known haemoglobinopathies
2. Anaemia of any type, defined by BSH guidelines
3. Severe gastrointestinal disease, affecting tolerability of oral iron
4. Allergies to iron
5. Multiple pregnancies, given the higher iron demands
6. Known haemochromatosis
7. Recent red cell transfusion, within 1 month
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method